Clinical Trial Update: Predictive Value of CEA and ctDNA in Lung Cancer Recurrence

View source ↗

Summary

A clinical trial is planned to assess whether CEA levels and circulating tumor DNA can predict recurrence in lung cancer; the study is currently not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Lung Carcinoma | Status: NOT_YET_RECRUITING